Page last updated: 2024-11-05

trihexyphenidyl and Encephalitis, Inclusion Body, Measles

trihexyphenidyl has been researched along with Encephalitis, Inclusion Body, Measles in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Six cases of subacute sclerosing panencephalitis (1 stage I, 3 stage II, 2 stage III) were diagnosed at our institution in the last 10 years."1.29Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis. ( da Costa, JC; da Silva, LF; Nunes, ML, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nunes, ML1
da Costa, JC1
da Silva, LF1

Other Studies

1 other study available for trihexyphenidyl and Encephalitis, Inclusion Body, Measles

ArticleYear
Trihexyphenidyl and isoprinosine in the treatment of subacute sclerosing panencephalitis.
    Pediatric neurology, 1995, Volume: 13, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Anticonvulsants; Antiparkinson Agents; Child; Child, Preschool; Drug

1995